← SynDRA
FLUDARABINE
SynDRA canonical compound SYN0011622 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | RRM1 |
|---|
| Mechanism of action | DNA synthesis inhibitor |
|---|
| Indication | chronic lymphocytic leukemia (CLL) |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
- ADA
- RRM1
- DCK
- POLA1
- RRM2
- POLD4
- POLD3
- POLD1
- POLD2
- POLE
- POLA2
- PRIM1
Mechanisms of action (all sources)
- DNA synthesis inhibitor
- ribonucleotide reductase inhibitor
- ADA INHIBITOR
- Purine antagonist
- DNA repair enzyme inhibitor
- POLA1 INHIBITOR
- DNA polymerase (alpha/delta/epsilon) inhibitor
- POLD4 INHIBITOR
- POLD3 INHIBITOR
- POLD1 INHIBITOR
- POLD2 INHIBITOR
- POLE INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- LMNA
- NFE2L2
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- NPY2R
- KCNH2
- IDH1
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HRH2
- HRH1
- HMGCR
- HIF1A
- NPY1R
- NR3C1
- ADORA1
- SIGMAR1
- TDP1
- TBXAS1
- TACR2
- TACR1
- SMAD3
- SLCO1B3
- SLC6A4
- SLC6A3
- SLC6A2
- SLC29A1
- SAMHD1
- NT5E
Drug classes
- Nucleic Acid Synthesis Inhibitors
- Antineoplastic Agents
- Antimetabolites
- Antimetabolites, Antineoplastic
- Immunologic Factors
- Immunosuppressive Agents
- Noxae
- Nucleoside Metabolic Inhibitor
ATC classes
Cross-references
Synonyms
- Fludarabina
- 2-f-araa
- 2-fluoro ara-a
- 2-fluorovidarabine
- Fluradosa
- NSC-118218
- NSC-118218H
- FaraA
- Fludarabinum
- Fludarabina [Spanish]
- Fludarabine [INN]
- Fludarabinum [Latin]
- SQ Fludarabine
- Fludara, Fludarabine
- Fludarabine (INN)
- Fluradosa (TN)
- F-Ara-A
- (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- 2-F-ara-A
- 2-Fluoro Ara-A
- 2-Fluoro-9-beta-D-arabinofuranosyladenine
- 9-beta-D-Arabinofuranosyl-2-fluoroadenine
- 9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine
- 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro-(9CI)
- 2-F-ARAA
- fludarabine phosphate impurity e (ep impurity)
- NSC 118218
- P2K93U8740
- CCRIS 3382
- 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro-
- DTXCID2019657
- 2-Fluoroadenine arabinoside
- NSC118218
- RefChem:58475
- L01BB05
- 2-Fluoro-9-beta-arabinofuranosyladenine
- 9-b-d-arabinofuranosyl-2-fluoroadenine
Reported adverse events
- P
- Evans syndrome
- Erythema multiforme
- Infection
- Myelosuppression
- Neoplasm
- Pneumonia
- Stevens-Johnson syndrome
- Skin toxicity
Look up FLUDARABINE in the interactive SynDRA portal →